A 3D Bioprinting Approach to Studying Retinal Müller Cells
Genes · 31.10.2024 · 15 (11) · 1414
DOI: 10.3390/genes15111414 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 31.10.2024. Verfasst von Davide Vecchiotti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Ependymoglial Cells, Bioprinting, Printing, Three-Dimensional, Cell Survival. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, University of L'Aquila, Ministry of Enterprises and Made in Italy.
Abstract (Originalsprache)
Background/Objectives: Bioprinting is an innovative technology in tissue engineering, enabling the creation of complex biological structures. This study aims to develop a three-dimensional (3D) bioprinted model of Müller cells (MCs) to enhance our understanding of their physiological and pathological roles in the retina.
Methods
We investigated two different hydrogels for their ability to support the viability and differentiation of rMC-1 cells, an immortalized retinal cell line. Using 3D bioprinting technology, we assessed cell viability, differentiation, and functional characteristics through various assays, including live/dead assays and western blot analysis.
Results
The collagen-based hydrogel significantly improved the viability of rMC-1 cells and facilitated the formation of spheroid aggregates, more accurately mimicking in vivo conditions compared to traditional two-dimensional (2D) culture systems. Moreover, 3D bioprinted MCs exhibited reduced markers of gliosis and oxidative stress compared to 2D cultures. Molecular analysis revealed decreased expression of GFAP and phosphorylated ERK in the 3D setting, indicating a less stressed cellular phenotype.
Conclusions
Our findings demonstrate that 3D bioprinting technologies provide a more predictive platform for studying the biology of retinal MCs, which can help in the development of targeted therapeutic strategies for retinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, 67100 L'Aquila, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
ORCID-Profile: Davide Vecchiotti, Mauro Di Vito Nolfi, Hafiz Nadeem Khan, Daniela Verzella, Daria Capece, Adriano Angelucci
Förderung
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila
- University of L'Aquila
- Ministry of Enterprises and Made in Italy
- intramural DISCAB GRANT 2022
- Progetto di Ricerca di Ateneo per l’avvio alla Ricerca
Zitieren
APA
Vecchiotti, D., Di Vito Nolfi, M., Veglianti, F., Dall'Aglio, F., Khan, H. N., Flati, I., Verzella, D., Capece, D., Alesse, E., Angelucci, A., & Zazzeroni, F. (2024). A 3D Bioprinting Approach to Studying Retinal Müller Cells. Genes, 15(11), 1414. https://doi.org/10.3390/genes15111414
Vancouver
Vecchiotti D, Di Vito Nolfi M, Veglianti F, Dall'Aglio F, Khan HN, Flati I, et al. A 3D Bioprinting Approach to Studying Retinal Müller Cells. Genes. 2024;15(11):1414. doi:10.3390/genes15111414
BibTeX
@article{Vecchiotti2024,
author = {Vecchiotti, Davide and Di Vito Nolfi, Mauro and Veglianti, Francesca and Dall'Aglio, Francesca and Khan, Hafiz Nadeem and Flati, Irene and Verzella, Daniela and Capece, Daria and Alesse, Edoardo and Angelucci, Adriano and Zazzeroni, Francesca},
title = {A 3D Bioprinting Approach to Studying Retinal Müller Cells},
journal = {Genes},
year = {2024},
volume = {15},
number = {11},
pages = {1414},
doi = {10.3390/genes15111414}
}
EUVIMED